News & Updates

Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis

04 Oct 2021

Collagen proportionate area (CPA) is a good predictor of long-term mortality in alcoholic hepatitis (AH) patients regardless of their abstinence from alcohol, a recent study has found. However, CPA seems to have no clear interaction with short-term mortality.

Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis

04 Oct 2021

Circulating tumour cells signal more aggressive HCC

08 Sep 2021 by

Circulating tumour cells are more frequently detected in peripheral blood samples of patients with more advanced than early-stage hepatocellular carcinoma (HCC), according to a study presented at the recently concluded Asian Pacific Digestive Week 2021.

Circulating tumour cells signal more aggressive HCC

08 Sep 2021

Lenvatinib benefit extends to Child-Pugh B HCC patients

04 Sep 2021 by

Lenvatinib confers better clinical outcomes than sorafenib in patients with unresectable hepatocellular carcinoma (uHCC) even when their liver function deteriorates to Child-Pugh B after initiation of treatment, according to a post hoc analysis of the REFLECT study.

Lenvatinib benefit extends to Child-Pugh B HCC patients

04 Sep 2021

Noninvasive markers identify LT recipients eligible for immunosuppression taper

04 Sep 2021

Noninvasive markers, including alanine aminotransferase (ALT) and liver stiffness measurements (LSM), may help distinguish liver transplant (LT) recipients for whom minimizing immunosuppression would be safe, a recent study has found.

Noninvasive markers identify LT recipients eligible for immunosuppression taper

04 Sep 2021

Ramucirumab + paclitaxel extends survival in gastric cancer, regardless of liver metastasis

02 Sep 2021 by

Adding the VEGFR*-2 antagonist ramucirumab to paclitaxel extends survival of patients with advanced gastric/GEJ** adenocarcinoma compared with paclitaxel alone, regardless of liver metastasis status, according to a post hoc analysis of the RAINBOW*** trial presented at the ESMO GI 2021 Congress.

Ramucirumab + paclitaxel extends survival in gastric cancer, regardless of liver metastasis

02 Sep 2021

Long-term dermatological surveillance valuable after liver transplant

30 Aug 2021 by

Though skin cancer incidence is low, liver transplant recipients may still benefit from long-term dermatological surveillance to help monitor malignancies and infections, according to a recent Singapore study.

Long-term dermatological surveillance valuable after liver transplant

30 Aug 2021

Nivolumab shows promise for advanced HCC

28 Aug 2021

Nivolumab shows clinical activity in patients with advanced hepatocellular carcinoma (aHCC) with Child-Pugh B status, accompanied by a favourable safety profile and manageable side-effects, a recent study has found.

Nivolumab shows promise for advanced HCC

28 Aug 2021

Acute viral hepatitis burden heaviest in low-income countries

26 Aug 2021

Socioeconomic development is inversely correlated with acute viral hepatitis (AVH), such that the disease burden is highest among low-income countries, a recent study has found.

Acute viral hepatitis burden heaviest in low-income countries

26 Aug 2021

Obesity, NAFLD may disqualify potential liver transplant donors

21 Aug 2021

Obesity and nonalcoholic fatty liver disease (NAFLD) may disqualify potential donors from being suitable for living donor liver transplantation (LDLT), a recent study has found.

Obesity, NAFLD may disqualify potential liver transplant donors

21 Aug 2021

Universal DAA access tied to reduced HCV prevalence in PLHIV

20 Aug 2021 by

Universal access to direct-acting antivirals (DAAs) may have led to the low prevalence of hepatitis C viraemia among people living with HIV (PLHIV) in The Netherlands, according to a study presented at IAS 2021.

Universal DAA access tied to reduced HCV prevalence in PLHIV

20 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis

Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis

Circulating tumour cells signal more aggressive HCC

Circulating tumour cells signal more aggressive HCC

Lenvatinib benefit extends to Child-Pugh B HCC patients

Lenvatinib benefit extends to Child-Pugh B HCC patients

Noninvasive markers identify LT recipients eligible for immunosuppression taper

Noninvasive markers identify LT recipients eligible for immunosuppression taper

Ramucirumab + paclitaxel extends survival in gastric cancer, regardless of liver metastasis

Ramucirumab + paclitaxel extends survival in gastric cancer, regardless of liver metastasis

Long-term dermatological surveillance valuable after liver transplant

Long-term dermatological surveillance valuable after liver transplant

Nivolumab shows promise for advanced HCC

Nivolumab shows promise for advanced HCC

Acute viral hepatitis burden heaviest in low-income countries

Acute viral hepatitis burden heaviest in low-income countries

Obesity, NAFLD may disqualify potential liver transplant donors

Obesity, NAFLD may disqualify potential liver transplant donors

Universal DAA access tied to reduced HCV prevalence in PLHIV

Universal DAA access tied to reduced HCV prevalence in PLHIV